CClinicalTrials.gg
CompletedNCT04609722Updated Feb 8, 2023

Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic

An interventional study of Solution-Focused Support Program in Anxiety, Parents and Covid19, sponsored by Adiyaman University Research Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-02-08.

Sponsored by Adiyaman University Research Hospital · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jul 2020, registered Oct 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

In this research, it was aimed to determine the anxiety levels of parents in the Covid-19 pandemic and to examine the effects of the Solution-Focused Support Program, which is planned to be given to parents with high anxiety levels.

Read the detailed description

The study is conducted with parents whose children aged 3-6 years, and have high anxiety levels. In collecting research data; an introductory information form prepared by researchers and the State-Trait Anxiety Inventory will be used.

02

Conditions studied

  • Anxiety
  • Parents
  • Covid19

Keywords

  • anxiety
  • child
  • nursing practice
  • parents
  • Solution-Focused Support Program
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 90 is close to the median of 100 across 4,099 interventional studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Adiyaman University Research Hospital is the lead sponsor of 48 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Parents with children aged 3-6,
  • Having internet at home or mobile phone,
  • Parents who volunteer to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Having communication problems,
  • Parents who have not attended at least one session
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    intervention group

    Solution-Focused Support Program will apply to the participants.

    Other: Solution-Focused Support Program

  • No intervention
    control group

    No intervention will be applied to the parents in the control group.

Interventions

  • OtherSolution-Focused Support Program

    All participants will be given a program of 4 sessions for 4 weeks. Each session is planned to last approximately 50 minutes.

06

What researchers measure

Primary outcomes

  1. State-Trait Anxiety Inventory (STAI)

    STAI was developed by Spielberg et al. In 1970 to measure the trait and state anxiety levels of individuals and was adapted to Turkish by Öner and Le Compte (1983) (Gilik and Avşaroğlu 2017). There are a total of 40 questions in the State-Trait Anxiety Scale. The State Anxiety Sub-Scale (STAI-S) evaluates how an individual feels at a particular time and under certain conditions. The Trait Anxiety Subscale (STAI-T) generally assesses how an individual feels. The scores obtained from both scales vary between 20 and 80. High score indicates high anxiety level, low score indicates low anxiety level.

    Time frame: 5 minutes

07

Study locations

1 site
  • Online- Data will be collected through the form created with the Google-Forms
    Adıyaman, 02100, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04609722
Lead sponsor
Adiyaman University Research Hospital
Responsible party
Mürşide Zengin (Adıyaman University, Adiyaman University Research Hospital) — Principal investigator
First posted
Oct 30, 2020
Start date
Jul 1, 2020
Primary completion
Dec 1, 2020
Completion
Apr 1, 2021
Last update
Feb 8, 2023

Study contacts

Ceyda Başoğul
principal investigator · Adiyaman University
Emriye Hilal Yayan
principal investigator · İnönü University
Mürşide Zengin
principal investigator · Adiyaman University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion